Contribution of vitamin D deficiency to the risk of coronary heart disease in subjects with essential hypertension

Atherosclerosis

Volumn 244, Issue , 2016, Pages 165-171

  Nargesi, Arash Aghajani ^a   Heidari, Behnam ^a   Esteghamati, Sadaf ^a   Hafezi Nejad, Nima ^a   Sheikhbahaei, Sara ^a   Pajouhi, Atieh ^a   Nakhjavani, Manouchehr ^a   Esteghamati, Alireza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary heart disease; Hypertension; Risk reclassification; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; COHORT ANALYSIS; CORONARY RISK; DIABETIC PATIENT; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; CORONARY ARTERY DISEASE; HYPERTENSION; INCIDENCE; IRAN; PREVALENCE; PROCEDURES; PROSPECTIVE STUDY; TIME FACTOR;

CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; IRAN; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84949257840     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.11.020     Document Type: Article

References (61)

1. Lozano R., Naghavi M., Foreman K., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
2. Murray C.J., Vos T., Lozano R., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
3. Program NHBPE The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 2004.
4. Wong N.D. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat. Rev. Cardiol. 2014, 11:276-289.
5. Lloyd-Jones D.M. Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 2010, 121:1768-1777.
6. Burgaz A., Orsini N., Larsson S.C., et al. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J. Hypertens. 2010, 29:636-645.
7. Song Y., Wang L., Pittas A.G., et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013, 36:1422-1428.
8. Ford E.S., Ajani U.A., McGuire L.C., et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28:1228-1230.
9. Wang L., Song Y., Manson J.E., et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 2012, 5:819-829.
10. Forrest K.Y., Stuhldreher W.L. Prevalence and correlates of vitamin D deficiency in US adults. Nutr. Res. 2011, 31:48-54.
11. Lee J.H., Gadi R., Spertus J.A., et al. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am. J. Cardiol. 2011, 107:1636-1638.
12. Zhao G., Ford E.S., Li C., et al. Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J. Hypertens. 2011, 30:284-289.
13. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
14. Heidari B., Nargesi A.A., Hafezi-Nejad N., et al. Assessment of serum 25-hydroxy vitamin D improves coronary heart disease risk stratification in patients with type 2 diabetes. Am. Heart J. 2015 Sep, 170(3):573-579.
15. Greenland P., Alpert J.S., Beller G.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2010, 56:e50-103.
16. Esteghamati A., Ashraf H., Rashidi A., et al. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res. Clin. Pract. 2008, 82:104-107.
17. Esteghamati A., Zandieh A., Khalilzadeh O., et al. Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population. Diabetol. Metab. Syndr. 2010, 2:36.
18. Esteghamati A., Abbasi M., Nakhjavani M., et al. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc. Diabetol. 2006, 5:15.
19. Nargesi A.A., Ghazizadeh Z., Larry M., et al. Manual or automated sphygmomanometer? a historical cohort to quantify measurement bias in blood pressure recording. J. Clin. Hypertens. Greenwich 2014, 16:716-721.
20. Ives D.G., Fitzpatrick A.L., Bild D.E., et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann. Epidemiol. 1995, 5:278-285.
21. Sacks D.B., Arnold M., Bakris G.L., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011, 34:e61-99.
22. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96:1911-1930.
23. Pencina M.J., D'Agostino R.B., Larson M.G., et al. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation 2009, 119:3078-3084.
24. Xue X., Kim M.Y., Shore R.E. Cox regression analysis in presence of collinearity: an application to assessment of health risks associated with occupational radiation exposure. Lifetime Data Anal. 2007, 13:333-350.
25. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
26. Pencina M.J., D'Agostino R.B., Vasan R.S. Statistical methods for assessment of added usefulness of new biomarkers. Clin. Chem. Lab. Med. 2010, 48:1703-1711.
27. Leening M.J., Vedder M.M., Witteman J.C., et al. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. Ann. Intern. Med. 2014, 160:122-131.
28. Giovannucci E., Liu Y., Hollis B.W., et al. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 2008, 168:1174-1180.
29. Pilz S., Dobnig H., Nijpels G., et al. Vitamin D and mortality in older men and women. Clin. Endocrinol. Oxf. 2009, 71:666-672.
30. Robinson-Cohen C., Hoofnagle A.N., Ix J.H., et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 2013, 310:179-188.
31. Michos E.D., Misialek J.R., Selvin E., et al. 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC study. Atherosclerosis 2015, 241:12-17.
32. Muscogiuri G., Mitri J., Mathieu C., et al. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur. J. Endocrinol. 2014, 171:R101-R110.
33. Maalmi H., Ordonez-Mena J.M., Schottker B., et al. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies. Eur. J. Cancer 2014, 50:1510-1521.
34. Littlejohns T.J., Henley W.E., Lang I.A., et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology 2014, 83:920-928.
35. Yin K., Agrawal D.K. Vitamin D and inflammatory diseases. J. Inflamm. Res. 2014, 7:69-87.
36. Bauer S.R., Hankinson S.E., Bertone-Johnson E.R., et al. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Med. Baltim. 2013, 92:123-131.
37. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
38. Kunutsor S.K., Burgess S., Munroe P.B., et al. Vitamin D and high blood pressure: causal association or epiphenomenon?. Eur. J. Epidemiol. 2014, 29:1-14.
39. Vaidya A., Williams J.S. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism 2011, 61:450-458.
40. Hagstrom E., Hellman P., Larsson T.E., et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009, 119:2765-2771.
41. Grandi N.C., Brenner H., Hahmann H., et al. Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart 2012, 98:926-933.
42. Van Hemelrijck M., Michaelsson K., Linseisen J., et al. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One 2013, 8:e61037.
43. Li K., Kaaks R., Linseisen J., et al. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart 2012, 98:920-925.
44. Bolland M.J., Grey A., Avenell A., et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011, 342:d2040.
45. Reddy Vanga S., Good M., Howard P.A., et al. Role of vitamin D in cardiovascular health. Am. J. Cardiol. 2010, 106:798-805.
46. Kunadian V., Ford G.A., Bawamia B., et al. Vitamin D deficiency and coronary artery disease: a review of the evidence. Am. Heart J. 2014, 167:283-291.
47. Anderson J.L., May H.T., Horne B.D., et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 2010, 106:963-968.
48. Wang L., Manson J.E., Song Y., et al. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 2010, 152:315-323.
49. Prince R.L., Austin N., Devine A., et al. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch. Intern. Med. 2008, 168:103-108.
50. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469.
51. Hsia J., Heiss G., Ren H., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846-854.
52. Ford J.A., MacLennan G.S., Avenell A., et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am. J. Clin. Nutr. 2014, 100:746-755.
53. Lutsey P.L., Michos E.D. Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies. Curr. Atheroscler. Rep. 2012, 15:293.
54. Michos E.D., Blumenthal R.S. Vitamin D supplementation and cardiovascular disease risk. Circulation 2007, 115:827-828.
55. Hatun S., Ozkan B., Bereket A. Vitamin D deficiency and prevention: Turkish experience. Acta Paediatr. 2011, 100:1195-1199.
56. Mishal A.A. Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos. Int. 2001, 12:931-935.
57. Hosseinpanah F., Yarjanli M., Sheikholeslami F., et al. Associations between vitamin D and cardiovascular outcomes; Tehran Lipid and Glucose Study. Atherosclerosis 2011, 218:238-242.
58. Hashemipour S., Larijani B., Adibi H., et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 2004, 4:38.
59. Stone N.J., Robinson J.G., Lichtenstein A.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2013, 63:2889-2934.
60. Enko D., Fridrich L., Rezanka E., et al. 25-hydroxy-Vitamin D status: limitations in comparison and clinical interpretation of serum-levels across different assay methods. Clin. Lab. 2014, 60:1541-1550.
61. Shoben A.B., Kestenbaum B., Levin G., et al. Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study. Am. J. Epidemiol. 2011, 174:1363-1372.